CDKN2A and astrocytoma (excluding glioblastoma): It is suspected that homozygous deletion of CDKN2A/B, which breaks the “brake” of tumor progression brake, nullifies the tumor‐suppressive environment created by IDH‐mutant astrocytomas.24, 25